Welcome to LookChem.com Sign In|Join Free
  • or
Xenazoic is a compound that has been identified through virtual screening against the TRβ agonist binding pocket. It is known by various brand names, including Cv 58903, Xenalmine, and Xenovis.

1174-11-4

Post Buying Request

1174-11-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1174-11-4 Usage

Uses

1. Used in Pharmaceutical Industry:
Xenazoic is used as a potential therapeutic agent for targeting the TRβ agonist binding pocket. Its identification through virtual screening suggests that it may have applications in the development of new drugs or treatments for various conditions related to the TRβ agonist.
2. Used in Drug Discovery and Development:
Xenazoic's discovery through virtual screening indicates its potential use in the drug discovery and development process. It may serve as a starting point for further research and optimization to create more effective and targeted medications.
3. Used in Research and Development of TRβ Agonist Inhibitors:
As Xenazoic has been identified to interact with the TRβ agonist binding pocket, it may be used in the research and development of TRβ agonist inhibitors. These inhibitors could potentially be used to treat conditions where TRβ agonist activity is a contributing factor.
4. Used in Virtual Screening Studies:
Xenazoic's identification through virtual screening highlights its potential use in other virtual screening studies. It may serve as a reference or benchmark for the development of new screening methods or the identification of other compounds with similar or improved properties.

World Health Organization (WHO)

Xenazoic acid, an antiviral agent, was introduced in the early 1960s. Its use was associated with hepatic toxicity which resulted in its withdrawal from the market in at least two countries in 1965. WHO has no information to suggest that xenazoic acid remains commercially available.

Check Digit Verification of cas no

The CAS Registry Mumber 1174-11-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,1,7 and 4 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1174-11:
(6*1)+(5*1)+(4*7)+(3*4)+(2*1)+(1*1)=54
54 % 10 = 4
So 1174-11-4 is a valid CAS Registry Number.
InChI:InChI=1/C23H21NO4/c1-2-28-22(24-20-14-12-19(13-15-20)23(26)27)21(25)18-10-8-17(9-11-18)16-6-4-3-5-7-16/h3-15,22,24H,2H2,1H3,(H,26,27)

1174-11-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[[1-ethoxy-2-oxo-2-(4-phenylphenyl)ethyl]amino]benzoic acid

1.2 Other means of identification

Product number -
Other names xenazoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1174-11-4 SDS

1174-11-4Relevant academic research and scientific papers

Method of treating diabetes mellitus using arylglyoxals

-

, (2008/06/13)

A method of treating diabetes mellitus using arylglyoxals which are known compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1174-11-4